01—Abstract
Summary
Summary of the 10-Q filed November 5, 2024. Cited figures are marked; the original filing is the authoritative source.
Gartner, Inc. (NYSE: IT) reported third-quarter 2024 total revenues of $1,484.3 milliona, up 5% from $1,408.8 million in the third quarter of 2023, with net income of $415.0 million versus $180.0 million a year earlier and diluted EPS of $5.32 versus $2.26.
The quarter's results were materially lifted by a $300.0 millionb gain on event cancellation insurance claims, recognized after a July 25, 2024 settlement resolving all remaining 2020 and 2021 claims. Operating income was essentially flat at $245.8 million versus $244.4 million, as higher cost of services and SG&A expenses offset revenue growth. Research revenue rose 5% to $1,280.9 million, Conferences revenue rose 32% to $75.8 million, and Consulting revenue fell 4% to $127.6 million.
Research contract value reached $5.04 billionc at September 30, 2024, up 7% excluding foreign currency impact. For the nine months ended September 30, 2024, revenue was $4,552.3 million (up 5%) and net income was $855.1 million (up 27%), while operating income declined 10% to $838.5 million because the prior-year period included a $135.4 million gain on the sale of TalentNeuron. Cash provided by operating activities rose to $1,149.6 million from $931.4 million, helped by the $300.0 million insurance proceeds, and the company repurchased $633.4 million of treasury stock during the period.
Cash and cash equivalents were $1.8 billiond at quarter-end, with approximately $707.0 million of available revolver capacity under the 2024 Credit Agreement. Balance sheet leverage remains significant, with $2.5 billion of principal debt outstanding against total stockholders' equity of $1,064.7 million, up from $680.6 million at December 31, 2023.
Management stated it believes liquidity is adequate for the next twelve months and the foreseeable future. Investors should weigh the one-time insurance gain against underlying operating income, which was broadly unchanged in the quarter.
02—Key points
Key Highlights
- Q3 2024 net income of $415.0 million and diluted EPS of $5.32, versus $180.0 million and $2.26 in Q3 2023, driven primarily by a $300.0 million gain on event cancellation insurance claims.
- Q3 2024 total revenues of $1,484.3 million, up 5% year over year; Research up 5%, Conferences up 32%, Consulting down 4%.
- Q3 2024 operating income of $245.8 million, essentially flat versus $244.4 million, as SG&A rose to $711.7 million from $660.5 million.
- Nine-month operating income declined to $838.5 million from $935.5 million, reflecting the prior-year $135.4 million gain on the TalentNeuron sale.
- Research contract value rose to $5.04 billion at September 30, 2024, up 7% excluding foreign currency; Global Business Sales contract value grew 12%.
- Cash from operations was $1,149.6 million for nine months versus $931.4 million, with $633.4 million used for share repurchases.
- Total debt principal of $2.5 billion at September 30, 2024, with $1.8 billion of cash and approximately $707.0 million of revolver availability.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2024, Gartner kept $0.28.
- Revenue$1.48B100.0%
- Cost of revenue−$468.9M31.6%
- Gross profit$1.02B68.4%
- Operating costs−$769.6M51.8%
- Operating income$245.8M16.6%
- Interest, other & tax$169.2M11.4%
- Net income$415.0M28.0%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2024filed November 5, 2024Financial Statements
Q3 FY2024 against Q3 FY2023
| Line item | Q3 FY2024Q3 FY2023 | Change |
|---|---|---|
| Revenue | $1.48B$1.41B | +5.4% |
| Cost of Revenue | $475.34M$450.84M | +5.4% |
| Gross Profit | $1.02B$957.94M | +6.0% |
| SG&A Expenses | $711.73M$660.53M | +7.8% |
| Operating Expenses | $1.24B$1.16B | +6.4% |
| Operating Income | $245.82M$244.42M | +0.6% |
| Net Income | $415.05M$180.01M | +130.6% |
| EPS (Basic) | $5.36$2.28 | +135.1% |
| EPS (Diluted) | $5.32$2.26 | +135.4% |
| Shares Outstanding (Basic) | 77.48M78.92M | −1.8% |
| Shares Outstanding (Diluted) | 77.97M79.52M | −2.0% |
05—Questions
Frequently Asked Questions
What drove the large increase in net income this quarter?
Net income rose to $415.0 million from $180.0 million mainly because of a $300.0 million gain on event cancellation insurance claims, recognized following a July 25, 2024 settlement. Revenue growth and lower net interest expense also contributed, partially offset by higher operating expenses.
Is underlying operating performance improving?
Operating income was $245.8 million, roughly flat with $244.4 million a year earlier. Revenue grew 5%, but cost of services and product development rose 5% and SG&A rose 8%, which absorbed most of the revenue gain.
How healthy is the Research business?
Research revenue increased 5% to $1,280.9 million in the quarter, and contract value grew 7% to $5.04 billion excluding foreign currency. Global Technology Sales client retention was 83% and Global Business Sales client retention was 87%, down from 88% a year earlier, with GBS wallet retention declining to 106% from 108%.
How is the company managing its capital and debt?
The company repurchased $633.4 million of stock in the nine months and borrowed $274.4 million under a new $1.0 billion revolving facility to refinance the 2020 Credit Agreement. Management states it believes it has adequate liquidity for the next twelve months and the foreseeable future, with $1.8 billion of cash and about $707.0 million of available revolver capacity.
06—Continue